Abigail Rotberg
Far Rockaway, NYNPI 1952046203
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,352 and has fallen 50.6% since, to $668 in 2025.
Across 148 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$618
- Ironshore Pharmaceuticals Inc.$442
- AbbVie$391
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$354
- Axsome Therapeutics, Inc.$232
- Neos Therapeutics, LP$208
- plus $979 from 10 others
What the payments were for
- Food & beverage$3,17498%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 26 | $618 |
| Ironshore Pharmaceuticals Inc. | 21 | $442 |
| AbbVie | 16 | $391 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $354 |
| Axsome Therapeutics, Inc. | 10 | $232 |
| Neos Therapeutics, LP | 11 | $208 |
| Collegium Pharmaceutical, Inc. | 10 | $203 |
| Alkermes, Inc. | 7 | $160 |
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| Lundbeck LLC | 6 | $122 |
| Vertical Pharmaceuticals, LLC | 5 | $80 |
| Almatica Pharma LLC | 3 | $71 |
| Supernus Pharmaceuticals, Inc. | 3 | $65 |
| Tris Pharma Inc | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Johnson & Johnson | 1 | $24 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.